Life sciences PE Firm, SK Capital, is to sell the drug substance business of the Noramco Group and Extractas Bioscience to Six-listed Siegfried Holding, a Switzerland-based CDMO. Following the transaction…
Switzerland: SK Capital to sell Noramco, Extractas Bioscience, and Purisys to Siegfried
…
…






